Official sanction of GH use in this context may also await additional large-scale studies, since the diversity of the population of PORs has led multiple authors to call for studies specifically addressing each subgroup (e.g., older women, polycystic ovary syndrome, and endometriosis) [265, 271]. This evidence concerns the gene GH1 and endometriosis.